Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Bortezomib and Temozolomide in Patients With Refractory Solid Tumors

NCT00544284 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00544284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00544284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Bortezomib and Temozolomide in Patients With Refractory Solid Tumors
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2005
Completion date
January 31, 2012
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, lymphoma, metastatic cancer, unspecified adult solid tumor, protocol specific